Article
Expert Review of Neurotherapeutics  (2015)

Masitinib for the treatment of mild to moderate Alzheimer’s disease.

Folch J.; Petrov, D; Ettcheto M.; Abat S; Lazarowski A.; Marin M.; Olloquequi J.; Auladell C.; Camins A.